Thrombotic thrombocytopenic purpura due to anti-ADAMTS13 antibodies in multiple myeloma

Clinical Nephrology

Volumn 81, Issue 3, 2014, Pages 210-215

  Yao, Hubert ^a   Monge, Matthieu ^a   Renou, Marianne ^a   Lecaque, Caroline ^a   Jauréguy, Maïté ^a   Presne, Claire ^a   Makdassi, Raïfah ^a   Choukroun, Gabriel ^a  

^a UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

Author keywords

Anti ADAMTS13 antibodies; Multiple myeloma; Thrombotic microangiopathy; Thrombotic thrombocytopenic purpura

Indexed keywords

ACUTE KIDNEY INJURY; ADAM PROTEINS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AUTOANTIBODIES; DEXAMETHASONE; FEMALE; HUMANS; IMMUNOGLOBULIN G; MELPHALAN; MULTIPLE MYELOMA; PLASMAPHERESIS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RENAL DIALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84894050393     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN107579     Document Type: Article

References (22)

1. Coppo P, Veyradier A. Microangiopathies thrombotiques: physiopathologie, diagnostic et traitement. Reanimation. 2005; 14: 594-603. doi:10.1016/j.reaurg.2005.10.008
2. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lämmle B. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolyticuremic syndrome. N Engl J Med. 1998; 339: 1578-1584. doi:10.1056/NEJM199811263392202 PubMed
3. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med. 1998; 339: 1585-1594. doi:10.1056/NEJM199811263392203 PubMed
4. Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azocar J, Seder RH, Hong SL, Deykin D. Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med. 1982; 307: 1432-1435. doi:10.1056/NEJM198212023072306 PubMed
5. Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Hellums JD. Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest. 1986; 78: 1456-1461. doi:10.1172/JCI112736 PubMed
6. Moake JL. Thrombotic microangiopathies. N Engl J Med. 2002; 347: 589-600. doi:10.1056/NEJMra020528 PubMed
7. Coppo P, Adrie C, Azoulay E, Leleu G, Oksenhendler E, Galicier L, Le Gall JR, Bussel A, Schlemmer B. Infectious diseases as a trigger in thrombotic microangiopathies in intensive care unit (ICU) patients? Intensive Care Med. 2003; 29: 564-569. PubMed
8. Chang JC, Naqvi T. Thrombotic thrombocytopenic purpura associated with bone marrow metastasis and secondary myelofibrosis in cancer. Oncologist. 2003; 8: 375-380. doi:10.1634/theoncologist.8-4-375 PubMed
9. Coppo P, Wolf M, Veyradier A, Bussel A, Malot S, Millot GA, Daubin C, Bordessoule D, Pène F, Mira JP, Heshmati F, Maury E, Guidet B, Boulanger E, Galicier L, Parquet N, Vernant JP, Rondeau E, Azoulay E, Schlemmer B. Réseau d'etude des microangiopathies thrombotiques de l'adulte. Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura. Br J Haematol. 2006; 132: 66-74. doi:10.1111/j.1365-2141.2005.05837.x PubMed
10. Blot E, Decaudin D, Veyradier A, Bardier A, Zagame OL, Pouillart P. Cancer-related thrombotic microangiopathy secondary to Von Willebrand factor-cleaving protease deficiency. Thromb Res. 2002; 106: 127-130. doi:10.1016/S0049-3848(02)00095-6 PubMed
11. Veyradier A, Meyer D. Thrombotic thrombocytopenic purpura and its diagnosis. J Thromb Haemost. 2005; 3: 2420-2427. doi:10.1111/j.1538-7836.2005.01350.x PubMed
12. Veyradier A, Obert B, Houllier A, Meyer D, Girma JP. Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases. Blood. 2001; 98: 1765-1772. doi:10.1182/blood. V98.6.1765 PubMed
13. Pene F, Vigneau C, Auburtin M, Moreau D, Zahar JR, Coste J, Heshmati F, Mira JP. Outcome of severe adult thrombotic microangiopathies in the intensive care unit. Intensive Care Med. 2005; 31: 71-78. doi:10.1007/s00134-004-2505-0 PubMed
14. Scrobohaci ML, Daniel MT, Levy Y, Marolleau JP, Brouet JC. Expression of GpIb on plasma cells in a patient with monoclonal IgG and acquired von Willebrand disease. Br J Haematol. 1993; 84: 471-475. doi:10.1111/j.1365-2141.1993. tb03103.x PubMed
15. Richard C, Cuadrado MA, Prieto M, Batlle J, López Fernández MF, Rodriguez Salazar ML, Bello C, Recio M, Santoro T, Gomez Casares MT, et al. Acquired von Willebrand disease in multiple myeloma secondary to absorption of von Willebrand factor by plasma cells. Am J Hematol. 1990; 35: 114-117. doi:10.1002/ajh.2830350210 PubMed
16. Taccone FS, Bouko Y, Robin V. Exceptional association of diffuse anaplastic myeloma with microangiopathic anemia. Eur J Intern Med. 2007; 18: 607-611. doi:10.1016/j.ejim.2007.02.026 PubMed
17. Alpay N, Uzun S, Bahat G, Yavuz S, Erten N, Tascioglu C. Thrombotic thrombocytopenic purpura associated with multiple myeloma. Blood Coagul Fibrinolysis. 2008; 19: 439-441. doi:10.1097/MBC.0b013e32830610ee PubMed
18. Hofmeister CC, Jin M, Cataland SR, Benson DM, Wu HM. TTP disease course is independent of myeloma treatment and response. Am J Hematol. 2010; 85: 304-306. doi:10.1002/ajh.21646 PubMed
19. Kida Y, Ishii T, Ando M, Kanda E, Suzuki H, Kida A, Yamashita T, Sakamaki H, Saito H. A case report of thrombotic thrombocytopenic purpura and severe acute renal failure post non-myeloablative allogeneic peripheral blood stem cell transplantation treated with plasma exchange and hemodialysis. Ther Apher Dial. 2007; 11: 402-406. doi:10.1111/j.1744-9987.2007.00504.x PubMed
20. Gallerani E, Lerch E, Romagnani E, Stathis A, Giardelli G, Zwhalen H, Marone C, Cavalli F. Thrombotic thrombocytopenic purpura associated with renal failure after autologous transplantation for multiple myeloma successfully treated with rituximab. Eur J Haematol. 2006; 77: 527-529. doi:10.1111/j.1600-0609.2006.00758.x PubMed
21. Kornacker M, Luft T, Ho AD, Schaefer HJ. Thrombotic microangiopathy after combined autografting-allografting for multiple myeloma - report of three cases. Eur J Haematol. 2005; 74: 250-253. doi:10.1111/j.1600-0609.2004.00372.x PubMed
22. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, SpasoffRA; Canadian Apheresis Study Group. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med. 1991; 325: 393-397. doi:10.1056/NEJM199108083250604 PubMed